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Abstract
The world’s largest carnivorous marsupial, the Tasmanian devil (Sarcophilus harrisii), is
facing extinction from a deadly, highly communicable cancer that has already decimated over
85% of devil populations in the wild: devil facial tumour disease (DFTD). DFTD cells
effectively evade recognition by the immune system, and every devil that contracts the disease
dies from it. Many attempts have been made at developing a vaccine that could help save this
now-threatened species. Heat shock proteins have been linked to enhanced immune recognition
of pathogens, making them potential candidates for acting as adjuvants to such a vaccine against
DFTD. In this study, the effect of heat shocking DFTD cells on HSP expression was assessed.
DFTD cells were heat shocked at 40oC for varying lengths of time, with the maximum being 24
hours. RNA expression was determined for HSP 27, HSP 60, HSP 70, and HSP 90, and relative
protein expression was determined for HSP 70 and HSP 90. HSP 27 was shown to have
significantly increased relative RNA expression after heat shocking when compared with
untreated cells. Relative RNA expression for HSP 60 was not found to be significant even after
heat shocking. Expression of HSP 70 increased significantly after being heat shocked for several
hours. Accordingly, the relative RNA expression for HSP 70 increased with length of time of
heat shocking. Finally, HSP 90 showed insignificant variation in protein expression when
compared with untreated cells, even after heat shocking; the same was found to be true of its
relative RNA expression. Heat shock proteins 27 and 70 show the most potential in being used to
initiate an immune response against DFTD cells in devils.

Keywords: animal pathology; immunology; veterinary science; Sarcophilus harrisii; devil facial
tumour disease; heat shock proteins
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1.0 Introduction
1.1 Background
Tasmania has long been known for its unique flora and fauna, many of which are
endemic to the island. Among these is a species known as the Tasmanian devil (Sarcophilus
harrisii), the largest carnivorous marsupial in the world. This is a title that S. harrisii acquired
less than a century ago with the extinction of the Tasmanian tiger (Thylacinus cynocephalus).
Now, S. harrisii is facing the same fate as the T. cynocephalus faced, but for a very different
reason: a relatively recently discovered infectious cancer that is decimating populations of devils
in the wild. Known as devil facial tumour disease (DFTD), this fatal cancer has led to the species
being listed as threatened in Tasmania, with the possibility of extinction looming in the not-sodistant future (Hawkins et al., 2006).
1.2 Spread and Manifestation of DFTD
Devil facial tumour disease is a highly communicable cancer that has already eliminated
85% of the population of S. harrisii in the wild (Norrie, 2012). The disease was first observed in
northeastern Tasmania in 1996. Since then, it has spread throughout most of Tasmania, thus far
avoiding only the northwestern part of the island. Even in 2007, population studies indicated that
DFTD was present in at least 60% of the Tasmanian mainland, which was likely an
underestimate due to the difficulty of monitoring the disease’s spread in more remote areas
(McCallum et al., 2007). Several locations in Tasmania have been extensively surveyed since the
arrival of the disease, including the Freycinet Peninsula (Lachish et al., 2007) and Mt. William
(Hawkins et al., 2006), both on the east coast. Researchers found that population decreases as
drastic as 60% and 75%, respectively, of S. harrisii had occurred since the disease was first
noted in these areas. The adult survival rate of devils in some areas including the Freycinet
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Peninsula has dropped to nearly zero (McCallum et al., 2007). If this trend continues throughout
the rest of Tasmania, extinction of S. harrisii may soon be a reality rather than just the threat it
was previously believed to be.
DFTD manifests itself in the form of large malignant tumours on the face and neck of
devils affected by the disease. The tumours grow uncontrollably, often blocking vision,
respiratory tracts, and the mouth area. Every devil that has ever been recorded with the disease
has died from it, resulting in a mortality rate of 100% for animals with DFTD. Most die from
starvation because of the obstruction of their ability to feed, as the tumours invade areas in and
around their mouths. Additionally, if the devils survive long enough, the tumours often
metastasize to internal organs; this can lead to organ failure and secondary infections (Murchison
et al., 2010).
1.3 Origin and Transmission of DFTD
Research indicates that DFTD originated from a single Schwann cell in a female S.
harrisii, called patient zero. This cell developed into a cancer cell and divided out of control to
become a tumour, a mass of cancer cells. The same cells that were present in that original tumour
have been in every S. harrisii that has since contracted the disease (Woods, 2014). This is
unusual in cancers and is due to the fact that the cancer cells themselves are the infectious
agents; DFTD is transmitted by allograft. An allograft is a tissue transplant from one animal to
another of the same species, though the genetic makeup of the two animals is not identical
(Pearse and Swift, 2006). The tumours are primarily transmitted between S. harrisii individuals
when they bite each other during fights and the tumour cells from an infected devil are implanted
into the healthy devil’s face. They also commonly contract the disease after feeding on the same
roadkill that a diseased devil fed on (Hawkins et al., 2006).
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The most compelling evidence for the allograft theory of transmission is the similarity in
the karyotypes and genotypes of the tumours. Each of the tumours examined in a study
conducted by Pearse and Swift (2006) had 13 chromosomes as opposed to the usual 14 in S.
harrisii, and both sex chromosomes were missing. The chromosomes that were present were
abnormal and mutated: one chromosome 6 and both chromosomes 2 were missing, and the long
arm of one chromosome 1 was absent. Among all of the tumours studied, there were no
intermediate stages between the normal arrangement of chromosomes and the arrangement of
chromosomes in tumours, indicative of the fact that the same tumour cells are implanted into
each individual that has the disease rather than the tumours developing independently in each
individual (Pearse and Swift, 2006). A study conducted by Murchison et al. in 2010 supports this
theory; the researchers found that the genotypes of each tumour studied were very similar to each
other but were distinctly different from the genotypes of both their hosts and of unaffected
individuals (Murchison et al., 2010).
1.4 Role of MHC
Because DFTD kills every animal infected with the disease, it is evident that DFTD cells
are not recognized by the immune systems of devils. Tumour cells effectively evade the immune
system and are not rejected at any point during their growth. The mechanism for this has been
recently investigated, and researchers have found that DFTD cells do not express cell surface
major histocompatibility complex (MHC) molecules (Siddle et al., 2013). MHC molecules are
essential for proper immune function in vertebrates, as they bind to peptide fragments from
pathogens and present them to the immune system for recognition by T-cells. T-cells then
destroy and kill the tumour cells (Alberts, 2002). MHC molecules, when activated and working
properly, can even induce an immune response by acting as antigens themselves and spurring the
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production of antibodies. MHC molecules are generally responsible for transplant rejection,
which does not occur in DFTD cells. In fact, DFTD cells seem to do the opposite by downregulating genes necessary for the processing of antigens (Siddle et al., 2013). S. harrisii has
very limited genetic diversity of MHC sequences, which in turn leads to restricted function of the
immune system in recognizing antigens on tumour cell surfaces (Morris et al., 2012). A study
conducted by Morris et al. in 2012 examined MHC diversity in devils that inhabited Australia
before European settlement; the researchers found that low diversity in devil MHC sequences
has been in S. harrisii populations for roughly 6,000 years. Moreover, they believe that this low
genetic diversity is responsible for the numerous population crashes experienced by devils in the
past and for their unusual susceptibility to diseases like DFTD (Morris et al., 2012). A study
conducted by Lane et al. (2012) revealed that devils from north-western Tasmania, where DFTD
has not yet infiltrated the population, had far higher diversity at their MHC genes than did devils
from eastern Tasmania, where the disease has affected the majority of the population. This is
further evidence that MHC sequences with low genetic diversity among individuals are linked
with higher susceptibility to diseases including DFTD (Lane et al. 2012). The inability of MHC
molecules in S. harrisii to effectively present DFTD antigens to T-cells for destruction has led to
interest in finding ways to improve MHC antigen processing. Molecules known as heat shock
proteins have been investigated as possible enhancers of MHC antigen recognition and
presentation to T-cells.
1.5 Heat Shock Proteins
Heat shock proteins (HSPs) are evolutionarily highly conserved proteins that are present
in every cell and are essential for proper cell function. There are many families of HSPs, all of
which fall under the bigger protein group of molecular chaperones. Molecular chaperone
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proteins work to ensure that protein chains fold into their proper conformations after translation,
which is crucial for determining and performing their functions (Suzue et al., 1997). HSPs are
well known for their ability to protect cells and their proteins from stressful conditions such as
heat, pH, and inflammation (Van Eden et al., 2013). Equally important, however, is the role of
certain HSPs in the immune system. Research done by Suzue et al. (1997) elucidates the role of
heat shock fusion proteins in immune function. Heat shock fusion proteins are heat shock
proteins derived from pathogens and covalently linked to ovalbumin, a protein that can stimulate
an allergic reaction in study subjects. The heat shock fusion proteins examined in this study were
found to function as deliverers of antigens to MHC presentation pathways. They were described
as being “promising candidates for vaccines…in populations of MHC-disparate individuals,”
(Suzue et al., 1997) including S. harrisii. Further, a more recent study conducted by Tobian et al.
in 2004 found that bacterial heat shock proteins enhanced MHC processing and presentation of
antigens to T-cells. The HSPs were shown to increase antigen peptide uptake, which in turn
resulted in enhanced MHC presentation of the antigen to the immune system. Tobian et al.
(2004) also mentioned the potential of bacterial heat shock proteins in vaccines intended to
enhance the presentation of antigens to T-cells for killing. Segal et al. (2006) followed this by
discussing the possibility of purifying HSPs from tumour cells along with antigenic peptides
from the same tumour cells. The HSPs could then be used as a vaccine to present the isolated
tumour-specific peptides to the T-cells within the immune system, forcing the immune system to
recognize the antigenic peptides as foreign and presenting them for destruction. Finally, a study
conducted by Li et al. (2006) showed that mice immunized with a vaccine containing heat shock
protein complexes survived being injected with tumour cells in much higher numbers than did
non-immunized mice. The heat shock protein complexes that were tested were shown to produce
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a specific anti-tumour immunity. Even heat shock proteins alone were shown to induce nonspecific immunity (Li et al., 2006). With the upregulation of HSPs in DFTD cells could come
increased effectiveness in MHC presentation of tumour cells to T-cells for destruction. The
purpose of this study was to investigate the possibility of using HSPs as adjuvants to a vaccine
intended to initiate an immune response against DFTD cells.
1.6 Research Questions
The questions investigated in this study were: are heat shock proteins 27, 60, 70, and 90
present in DFTD cells? Can they be upregulated by heat shocking them, and which length of
incubation time results in the highest level of upregulation? Can these heat shock proteins be
considered as potential DFTD vaccine adjuvants?
1.7 Justification for Study
This study is extremely important and urgently required, because DFTD has already
wiped out as much as 85% of the population of Tasmanian Devils in the wild. It is a highly
transmissible cancer that has a 100% mortality rate – no devil infected will survive. With a
rapidly decreasing number of healthy devils found in Tasmania, it is crucial to develop a method
for immunizing the animals that have not yet been affected by the disease. Although preliminary
vaccines have been created, none have been successful in initiating an immune response strong
enough to prevent a tumour from forming. An adjuvant is needed to enhance the effect of the
vaccine, and the heat shock proteins investigated in this study could hold the key. The findings of
this study could be a step toward designing a more effective vaccine against DFTD and
ultimately to saving the threatened S. harrisii.
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1.8 Study Aims
This study was part of an ongoing project at Menzies Institute for Medical Research at the
University of Tasmania with the overarching goal of developing a vaccine that can immunize
Tasmanian Devils against DFTD and save the species from extinction. More specifically, this
study aimed to investigate the possibility of using heat shock proteins as adjuvants to this
vaccine. The plan for this study was first to determine whether heat shock proteins 27, 60, 70,
and 90 are present in Tasmanian Devil Facial Tumor Disease (DFTD) cells. Then, if they were
found to be present, the next goal was to upregulate these proteins in DFTD cells by heat
shocking the cells for varying lengths of time; the purpose of this was to identify the ideal
conditions for maximal protein upregulation and minimal cell death. Heat shock proteins are
important for an immune response, and because DFTD seems to be able to evade Tasmanian
devils’ immune systems, the upregulation of HSPs could result in a stronger immune response
against DFTD cells. Preliminary methods for heat shocking the HSPs of interest were based on
Dokladny et al. (2006) but were modified in further experiments.

2.0 Methods
2.1 Study Site
This study took place at Menzies Institute for Medical Research, an institution of the
University of Tasmania in Hobart, Tasmania. The facilities make up what is known as the
University of Tasmania Medical Science Precinct. The institute was established in 1988 and has
since become a world-class medical research facility, participating in both clinical and basic
science research. Menzies Institute for Medical Research was the ideal location for this study for
several reasons. Its geographic proximity to areas of Tasmania that have been ravaged by DFTD
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made it convenient for sample collection from diseased devils and for testing the effectiveness of
immunization with preliminary vaccines. Additionally, the institute is able to work closely with
and receive funding from the Save the Tasmanian Devil Program, which is also located in
Hobart. Finally, the superior facilities at Menzies Institute for Medical Research and extensive
previous research done there on DFTD made this research possible
2.2 Study Organisms
2.2.1 Sarcophilus harrisii
The Tasmanian devil, Sarcophilus harrisii, is a carnivorous marsupial of the family
Dasyuridae, found in the wild only in Tasmania, Australia. They are distributed throughout all of
Tasmania, living both in forested areas and in more urban areas. Devils are characterized by their
wiry black-brown fur with occasional white patches, and they are usually the size of a small dog.
They tend to inhabit hollowed logs and caves and are most active at night. Tasmanian devils are
fierce hunters, feeding mostly on birds, snakes, small mammals, and often on roadkill. Pound for
pound, they have one of the strongest bites of all mammals because of their muscular jaws.
Devils are solitary and protective of their territories, earning their names because of such
behaviors as lunging, baring their teeth, snarling, and biting at encroaching devils or other
predators (National Geographic, n.d.). Despite having seemingly healthy immune responses, the
species has an unusual flaw in their immune systems in regards to not rejecting devil facial
tumour disease cells that are implanted into their bodies (Woods, 2014). This makes them an
appropriate study species for this project investigating the use of heat shock proteins to enhance
an immune response against cancer cells.
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2.2.2 Heat Shock Proteins
Heat shock proteins are highly conserved intracellular molecules that are responsible for
several important cell functions, including the folding and transfer of proteins and the induction
of immune responses to pathogens. They are particularly important for the presentation of
antigens to T-cells and for the activation of these T-cells (Segal et al., 2013).
The heat shock proteins studied in this project are HSP 27, HSP 60, HSP 70, and HSP 90.
HSPs are named and grouped into families based on their molecular masses in kilodaltons (kDa);
HSP 27 is in the small heat shock protein family and is 27 kDa, HSP 60 is in the HSP 60 family
and is 60 kDa, HSP 70 is in the HSP 70 family and is 70 kDa, and HSP 90 is in the HSP 90
family and is 90 kDa (Calderwood et al., 2006). All four of these HSPs have similar functions:
they recognize proteins that are denaturing due to stressful environmental conditions, and they
protect them from aggregation while aiding in their refolding. Their important function in the
immune system is to assist the MHC in presenting antigens to T-cells for destruction. Heat shock
proteins were chosen to be studied as potential vaccine adjuvants because they have shown
promising results in previous studies in enhancing MHC antigen processing and presentation to
T-cells. HSPs are a good possibility for acting as adjuvants in an anti-DFTD vaccine because
there is generally no autoimmune reaction of the individual against HSPs derived from
pathogens. This is due to the fact that HSPs from pathogens and the corresponding proteins in
mammals can be as much as 50% identical at the amino acid level, and the immune system does
not recognize the pathogen-derived HSPs as “non-self” (Lamb et al., 1989). Heat shock proteins
27, 70, and 90 in particular were chosen for this study because HSP 70 and HSP 90 are known to
be present in DFTD cells and HSP 27 is thought to be present. These HSPs have been well
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studied in other organisms and there is much literature describing their function in the immune
system. HSP 70 specifically has been shown to be highly immunogenic, or effective at initiating
an immune response, and HSP 90 has been shown to be slightly immunogenic (Udono and
Srivastava, 1994). Additionally, they were convenient to use because antibodies against each of
these HSPs were available. Most importantly for this study, HSP 27, HSP 70, and HSP 90 were
all found to be increasingly expressed with heat treatment in a study conducted by Dokladny et
al. (2006) using a method similar to the one used in this study.
2.3 Western Blot to Determine Presence of HSP 27 and HSP 70
Western blot analysis was used to detect heat shock protein 27 in DFTD cells. Protein
previously extracted from DFTD cells and stored at -80oC was prepared with LDS buffer, a
reducing agent, and deionized water. A total of 10 µL of this solution was loaded into each well
of a gel (4%-12% Bis-Tris Protein Gel; Life Technologies) along with a pre-stained protein
ladder. The gel was allowed to run for 35 minutes with MES buffer at a constant voltage of 165
V. The gel was then dry-transferred onto a nitrocellulose membrane for 7.5 minutes (iBlot Dry
Blotting System; Life Technologies) and washed with a blocking buffer solution (1X iBind
Solution; Life Technologies). The Western blot was then performed: the membrane was then
placed on an iBind card in the iBind Western Device (Life Technologies) with the protein-side
down. A total of 2 mL of the diluted primary antibody [mouse anti-human HSP 27 (1/1,000)]
was added to the first well in the device, 2 mL of the blocking buffer were added to the second
well, 2 ml of the diluted secondary antibody [goat anti-mouse HRP (1/1,000)] were added to the
third well, and 6 mL of the blocking buffer were added to the fourth well. The membrane was
allowed to incubate for 2.5 hours and was then rinsed in distilled water for 2 minutes. The
membrane was then stained with a chemiluminescent substrate solution (Immobilon Western
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Chemiluminescent HRP Substrate; Merck Millipore) and incubated for 5 minutes. Finally, the
membrane was imaged for 2 minutes using Carestream Molecular Imaging with the setting
Chemiblot: standard signal. The procedure for just the Western blot was repeated for HSP 70 the
following day to detect HSP 70 using the same membrane; the primary antibody used was mouse
anti-human HSP 70 (1/1000) and the secondary antibody used was goat anti-mouse HRP
(1/5000).
2.4 Heat Course Trials for RNA Extraction – Version 1
DFTD cells (C5065 cell line) that had been growing in culture were collected,
centrifuged at 300 x g for 10 minutes at room temperature, and re-suspended in 6 mL of
complete media [RPMI medium (RPMI 1640, USA) + 10% fetal calf serum + 5% GlutaMAX +
5% Antibiotic-antimycotic (Anti-Anti); Gibco]. Six 1.5 mL tubes (Eppendorf Safe-Lock
Microcentrifuge Tubes) were filled with 800 µL of this solution each. The cell concentration was
2.8 x 106 cells per mL, or 2.24 x 106 cells per 800 µL. Each of the tubes of cells was designated
to be heated for a certain number of hours: one for zero (0) hours, one for two (2) hours, one for
four (4) hours, one for eight (8) hours, one for eighteen (18) hours, and one for twenty-four (24)
hours. All of the tubes except the 0 hour tube were placed in a heating block set to 41oC. The
tubes were individually taken out of the heating block after they incubated for their designated
amount of time, staggering the rest of the procedure; for the 0 hour tube, the following steps
were started immediately without any incubation. Right after removal from the heating block, the
cell viability for each tube was checked. The tubes were then centrifuged at 14,000 rpm in a
microcentrifuge to pellet the cells. The supernatant was decanted and the cells were re-suspended
in 1 mL of reagent for isolation of total RNA (TRI Reagent Solution; Life Technologies). The
tubes were stored at 4oC until RNA extraction. This experiment was stopped after the 4 hour cell
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viability check because more than 50% of the cells were not viable. The method was modified
and is described below.
2.5 Heat Course Trials for RNA Extraction – Version 2
DFTD cells (C5065 cell line) that had been growing in culture were collected,
centrifuged at 300 x g for 10 minutes at room temperature, and re-suspended in 6.5 mL of
complete media [RPMI medium (RPMI 1640, USA) + 10% fetal calf serum + 5% GlutaMAX +
5% Antibiotic-antimycotic (Anti-Anti); Gibco, USA]. Six wells in a cell culture cluster plate
were filled with 800 µL of this solution each. An additional 1 mL of complete culture media was
added to each of the wells. These were incubated overnight in an incubator set to 35oC. Each of
the wells of cells was designated to be heated for a certain number of hours: one for zero (0)
hours, one for two (2) hours, one for four (4) hours, one for eight (8) hours, one for eighteen (18)
hours, and one for twenty-four (24) hours. All of the wells except the 0 hour one were placed in
an incubator set to 40oC. The wells were individually taken out of the incubator after they
incubated for their designated amount of time, staggering the rest of the procedure; for the 0 hour
well, the following steps were started immediately after removal from the 35oC incubator. The
cell viability for each well was checked (all were >95% viable). The cells were then washed
from the bottom of the wells with 2 mL of new complete media and transferred to new 2 mL
tubes (Eppendorf Safe-Lock Microcentrifuge Tubes). The tubes were then centrifuged at 14,000
rpm in a microcentrifuge to pellet the cells. The supernatant was decanted and transferred into
individual tubes, and the cells were re-suspended in 1 mL of reagent for isolation of total RNA
(TRI Reagent Solution; Life Technologies). The tubes were stored at 4oC until RNA extraction.
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2.6 RNA Extraction
A total of 0.2 mL of chloroform was added to the tubes with samples obtained in the heat
course trial, and the tube was shaken vigorously to combine. The samples were incubated for 10
minutes at room temperature to allow the phases to settle, and they were centrifuged at 4oC at
12,000 x g for 15 minutes. The aqueous phases of the samples were removed and placed into
new individual tubes (Eppendorf Safe-Lock Microcentrifuge Tubes). To isolate the RNA, 0.5
mL of 100% isopropanol was added to each tube and the tubes were inverted to mix. The tubes
were incubated at room temperature for one hour and were centrifuged at 12,000 x g for 20
minutes at 4oC to pellet the RNA. To wash the RNA, the supernatant was removed from the
tubes, leaving only the RNA pellets. The pellets were washed with 1 mL of 75% ethanol. The
samples were then vortexed briefly and centrifuged at 7,500 x g for 5 minutes at 4oC. The
supernatants were discarded, and the wash procedure was repeated. The ethanol was then
pipetted off and the pellets were allowed to dry for 10 minutes. The RNA pellets were then resuspended in 50 µL of TE buffer (Tris-EDTA Buffer; Life Technologies) by passing the solution
up and down several times through a pipette tip. The tubes were incubated in a heating block at
60oC for 15 minutes to completely dissolve the RNA. Next, 5 µL of a DNase buffer (10X
TURBO DNase Buffer; Life Technologies) and 1 µL of a DNase (TURBO DNase; Life
Technologies) were added to 50 µL of the RNA and mixed gently. The tubes were incubated at
37oC for 30 minutes. A total of 5 µL of re-suspended DNase inactivation reagent (DNase
Inactivation Reagent; Life Technologies) was added and the solutions were mixed well. The
tubes were then incubated at room temperature for 5 minutes, being flicked every 2 minutes. The
tubes were then centrifuged at 10,000 x g for 1.5 minutes to pellet the reagent, and the RNA
suspensions were transferred to new tubes. The amount and purity of the RNA was quantified
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using a Nanodrop; the machine was initialized with 2 µL of water and was blanked with 2 µL of
TE buffer. Then, 2 µL of each RNA sample were placed on the Nanodrop individually for
quantification. The RNA samples were then diluted to a concentration of 100 ng/µL. Next, in
200 µL tubes (0.2 mL Individual Thin-Walled PCR Tubes; Bio-Rad) on ice, a template-primer
mix was prepared for each reaction by adding the following components in the order listed: 5 µg
total RNA in a 9 µL volume of TE buffer and 1 µL Oligo(dT)15 primer [Oligo(dT)12-18 Primer;
Life Technologies]. An additional reaction was included as a “no reverse transcriptase control”
for identification of any contaminating DNA. The template-primer mixtures were denatured in a
thermal cycler with a heated lid by heating the samples for 5 minutes at 70oC and then cooling
for 5 minutes at 4oC. The tubes were centrifuged and placed on ice. A reaction master mix was
then prepared in an Eppendorf tube for the samples by adding the following components in the
order listed: 25.5 µL of nuclease-free water, 68 µL of reaction buffer (GoScript 5X Reaction
Buffer; Promega), 34 µL of MgCl2, 17 µL of PCR nucleotide mix (PCR Nucleotide Mix10 mM;
Promega), 8.5 µL of ribonuclease inhibitor (Recombinant RNasin Ribonuclease Inhibitor;
Promega), and 1 µL of reverse transcriptase (GoScript Reverse Transcriptase; Promega) to all
samples except the control, where water was added instead. The internal control used was 18S
rRNA because it shows low variance in expression. Then, 10 µL of the master mix was pipetted
into the appropriate template-primer mixes for a final reaction volume of 20 µL. This was mixed
gently and centrifuged briefly. The samples were then placed in a thermal block cycler with a
heated lid at 25oC for 5 minutes, 42oC for one hour, 72oC for 15 minutes, and 4oC hold. The
reaction was stopped by placing the tubes on ice.
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2.7 Quantitative Reverse Transcriptase PCR of RNA Samples
A quantitative PCR was performed on the RNA extracted from the heat shocked DFTD
cells with specific primers for HSP 27, HSP 60, HSP 70, and HSP 90 (Appendix 1, Table A2).
The PCR primers used were diluted to 5 µM with nuclease-free water. A PCR master mix was
prepared for 21 reactions with10 µL each total. The following were added together in order: 105
µL of hot start reaction mix (FastStart DNA Master SYBR Green; LightCycler), 12.6 µL of
forward primer (5 µM), 12.6 µL of reverse primer (5 µM), and 37.8 µL of PCR-grade water. The
master mix was mixed carefully and was briefly centrifuged. Then, 8 µL of the master mix were
pipetted into each well of a 96-well PCR plate. Next, 2 µL of the appropriate cDNA samples
were added to the appropriate wells. The plate was covered with self-adhesive foil and briefly
centrifuged to pool the samples at the bottom of the wells. The program LightCycler 480 SW 1.5
was used for the analysis with the following detection format settings: SYBR Green 1/HRM
Dye/Block Size 96/Reaction Volume 10. The experiment was started with pre-set settings. Cycle
threshold values were recorded and melt curves were obtained.
2.8 Western Blot on Supernatant Samples
Western blots were performed on the supernatant samples from the heat course trial to
investigate whether heat shock proteins 27, 70, and 90 were released into the supernatant during
heat shocking. Protein from the supernatant samples was prepared with LDS buffer, a reducing
agent, and deionized water. A total of 10 µL of this solution was loaded into each well of three
gels (4%-12% Bis-Tris Protein Gel; Life Technologies); one for HSP 27, one for HSP 70, and
one for HSP 90. A pre-stained protein ladder was also run in a lane on each of these gels. The
gels were allowed to run with MES buffer for 35 minutes at a constant voltage of 165 V. The
gels were then dry-transferred onto nitrocellulose membranes for 7.5 minutes (iBlot Dry Blotting
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System; Life Technologies). The membranes were blocked for one hour at 4oC in blocking
buffer (Animal-Free Blocker; Vector Laboratories) and were rinsed once with TBS-Tween. The
membranes were then incubated in 50 mL tubes (50 mL Centrifuge Tubes; Corning) at room
temperature with the appropriate primary antibodies diluted in blocking buffer. The primary
antibodies used were as follows: HSP 27: mouse anti-human HSP 27 (1/1,000), HSP 70: mouse
anti-human HSP 70 (1/1,000), HSP 90: rabbit (serum) anti-human HSP 90 (1/20,000). After this
incubation, the membranes were washed a total of four times in TBS-Tween: once for ten
minutes and three times for five minutes each. The membranes were then incubated at room
temperature with the appropriate secondary antibodies diluted in blocking buffer. The secondary
antibodies used were as follows: HSP 27: goat anti-mouse HRP (1/1,000), HSP 70: goat antimouse HRP (1/4,000), HSP 90: goat anti-rabbit HRP (1/4,000). The membranes were washed
four times as described before. The membranes were then stained with a chemiluminescent
substrate solution (Immobilon Western Chemiluminescent HRP Substrate; Merck Millipore) and
incubated for 5 minutes. Finally, the membranes were imaged for 2 minutes each using
Carestream Molecular Imaging with the setting Chemiblot: standard signal.
2.9 Heat Course Trials for Protein Extraction
The DFTD cells (C5065 cell line) that were used for this experiment were grown in
culture, injected into a mouse to grow as a tumour, and then harvested and grown in cell culture
flasks. For this heat course trial, eight different lengths of incubation time were used. The DFTD
cells were collected from the flask in which they were growing and were split into eight small
flasks (CellBIND® Surface Cell Culture Flasks; Corning) with 5 mL of complete media [RPMI
medium (RPMI 1640, USA) + 10% fetal calf serum + 5% GlutaMAX + 5% Antibioticantimycotic (Anti-Anti); Gibco]. Each of the flasks of cells was designated to be heated for a
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certain number of hours: one for zero (0) hours, one for two (2) hours, one for four (4) hours, one
for six (6) hours, one for eight (8) hours, one for nine (9) hours, one for eighteen (18) hours, and
one for twenty-four (24) hours. All of the flasks except the 0 hour one were placed in an
incubator set to 40oC. The flasks were individually taken out of the incubator after they
incubated for their designated amount of time, staggering the rest of the procedure; for the 0 hour
flask, the following steps were started immediately after harvesting the cells. The cell viability
for each flask was checked (all were >90% viable). The cells were then washed from the bottom
of the flasks with the existing media and were transferred to new 10 mL tubes (10 mL Graduated
Centrifuge Tube; Techno Plas). The tubes were then centrifuged at 300 x g for 5 minutes, and the
supernatant was discarded. The cells were washed twice in cold PBS and then were pelleted by
centrifuging again at 300 x g for 5 minutes. The pellet was re-suspended 1 mL cold PBS
solution, and the cell suspension was transferred to a pre-weighted 1.5 mL tubes (Eppendorf
Safe-Lock Microcentrifuge Tubes). The cell viability was then checked. The cells were pelleted
for 60 seconds in a microcentrifuge at 14,500 rpm, and the supernatant was discarded. The
weights of the wet cell pellets were recorded. The tubes were then submerged in liquid nitrogen
and transferred to a -80oC freezer.
2.10 Protein Extraction
To extract the protein from the cell pellets, 280 µL of RIPA buffer (1X RIPA Lysis and
Extraction Buffer; Thermo Scientific) were added to each cell pellet. The mixture was pipetted
up and down to suspend the pellet. The pellets were then sonicated for 10 seconds with 50%
pulse. The mixture was shaken gently for 15 minutes at 4oC and then centrifuged at 14,000 x g
for 15 minutes at 4oC to pellet cell debris. The supernatants were then transferred to new clean
tubes and the amount of protein in each sample was quantified.
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2.11 Western Blot on Extracted Protein Samples
Western blots were performed on the protein samples from the heat course trial. Protein
from the samples was prepared with LDS buffer, a reducing agent, and deionized water. A total
of 10 µL of this solution was loaded into each well of five separate gels (4%-12% Bis-Tris
Protein Gel; Life Technologies); one for HSP 27, one for HSP 70, one for HSP 90, and two
negative control gels: one for mouse IgG and one for rabbit IgG. A pre-stained protein ladder
was also run in a lane on each of these gels. The gels were allowed to run for 35 minutes with
MES buffer at a constant voltage of 165 V. The gels were then dry-transferred onto
nitrocellulose membranes for 7.5 minutes (iBlot Dry Blotting System; Life Technologies). The
membranes were blocked for one hour at 4oC in blocking buffer (Animal-Free Blocker; Vector
Laboratories) and were rinsed once with TBS-Tween. The membranes were then incubated in 50
mL tubes (50 mL Centrifuge Tubes; Corning) at room temperature with the appropriate primary
antibodies and the controls diluted in blocking buffer. The primary antibodies used were as
follows: HSP 27: mouse anti-human HSP 27 (1/1,000), HSP 70: mouse anti-human HSP 70
(1/1,000), HSP 90: rabbit (serum) anti-human HSP 90 (1/20,000), Mouse IgG Control: mouse
IgG (1/200), Rabbit IgG control: rabbit IgG (1/20,000). In addition, as controls, 2 µL of alphatubulin mouse (1/5,000) were added to the tubes with the HSP 27 and HSP 70 membranes and 2
µL of actin rabbit (1/5,000) were added to the tube with the HSP 90 membrane. After this
incubation, the membranes were washed a total of four times in TBS-Tween: once for ten
minutes and three times for five minutes each. The membranes were then incubated at room
temperature with the appropriate secondary antibodies diluted in blocking buffer. The secondary
antibodies used were as follows: HSP 27: goat anti-mouse HRP (1/5,000), HSP 70: goat antimouse HRP (1/5,000), HSP 90: goat anti-rabbit HRP (1/5,000), Mouse IgG Control: goat anti-
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mouse HRP (1/5,000), Rabbit IgG Control: goat anti-rabbit HRP (1/5,000). The membranes were
washed four times as described before. The membranes were then stained with a
chemiluminescent substrate solution (Immobilon Western Chemiluminescent HRP Substrate;
Merck Millipore) and incubated for 5 minutes. Finally, the membranes were imaged for two
minutes each using Carestream Molecular Imaging with the setting Chemiblot: standard signal.
The blots were then quantified by measuring the band intensities of HSP 70, HSP 90, actin, and
tubulin using the ImageJ program.
2.12 Data Analyses
The relative expression of HSPs 27, 60, 70, and 90 according to the Quantitative PCR
was assessed using a two-way analysis of variance (ANOVA) with incubation time and heat
shock protein as the independent variables (Appendix 1, Table A1). P<0.05 was considered
statistically significant.
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3.0 Results
3.1 Western Blot to Determine Presence of HSP 27 and HSP 70
The image taken of the Western blot for HSP 27 revealed no bands. To eliminate the
possibility that this was due to human error such as faulty protein transfer onto the membrane,
the Western blot only was repeated using the same membrane with antibodies specific to HSP
70. That image revealed eight bands equal in size across the gel at 70 kDa.
3.2 Quantitative Reverse Transcriptase PCR of RNA Samples

Figure 1 Relative expression of heat shock proteins 27, 60, 70, and 90 in DFTD cells
represented as a fold-change when compared with untreated cells. All cells were incubated in an
incubator at 40oC for varying lengths of time (0, 2, 4, 8, 18, or 24 hours). Bars represent ± s.e.
****=p≤0.0001, **=p≤0.01, unlabeled=not significant.

Figure 1 shows the relative expression of RNA for specific HSPs from heat shocked
DFTD cells as a fold-change when compared to untreated cells. Overall, RNA for HSP 27 had
the highest relative expression of all of the heat shock proteins tested. Its relative expression was
the highest at 8 hours of incubation, nearly 128-fold higher than that of the untreated cells. All of
the incubation times tested on RNA for HSP 27, with the exception of 2 hours (p>0.05), showed
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significantly higher relative expression when compared with the untreated cells (p ≤0.0001).
RNA for HSP 60 saw minimal change in its relative expression throughout the entire heat course.
Although its relative expression was highest at 4 hours, being nearly 4-fold higher than that of
untreated cells, none of the incubation times showed a significant relative expression when
compared with the untreated cells (p>0.05). RNA for HSP 70 had the second highest relative
expression overall. Its relative expression was the highest at 24 hours of incubation, nearly 64fold higher than that of the untreated cells. The most significant fold-changes occurred at the 8,
18, and 24 hour incubation times (p≤0.0001), but a significantly higher relative expression was
also seen after 4 hours (p≤0.01). Only the 2 hour incubation time did not show a significant foldchange when compared with the untreated cells (p>0.05). Finally, RNA for HSP 90 seemed to
show the least change in relative expression. None of the incubation times tested showed a
significant relative expression when compared with the untreated cells (p>0.05). After 18 and 24
hours, HSP 90 even had lower relative expression than did the untreated cells.
3.3 Western Blot on Supernatant Samples
The images taken of the Western blot on the supernatant samples with HSP 70 and HSP
90 both showed a row of very intense bands around 55 kDa, while the image of HSP 27 showed
faint bands in the same area. No other bands were detected in any of the images.
3.4 Western Blot on Extracted Protein Samples
The image taken of the Western blot with HSP 27 showed one row of bands at around 55
kDa that were all even in intensity. The image taken of the Western blot with HSP 70 also
showed one row of bands at around 55 kDa, but another fainter row of bands appeared in this
image at around 70 kDa. Both rows of bands seemed to be decreasing in intensity across the
length of the membrane. The image taken of the Western blot with HSP 90 showed one row of
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bands around 45 kDa that decreased slightly in intensity across the membrane as well as a fainter
row of bands around 90 kDa that also seemed to decrease slightly in intensity across the
membrane. The image of the Mouse IgG control Western blot showed no bands, indicating that
there was no non-specific binding of the antibodies. The image of the Rabbit IgG control
Western blot showed some bands across the membrane, indicating the presence of some nonspecific binding of the antibodies.

Figure 2 Band intensity revealing expression of heat shock proteins 70 and 90 from DFTD cells
as well as tubulin and actin controls; represented as percentages of the total intensity of the bands
in a particular membrane. All cells were incubated in an incubator at 40oC for varying lengths of
time (0, 2, 4, 6, 8, 9, 18, or 24 hours).
The ImageJ band intensity quantification revealed the intensity of each of the bands in the
HSP 70 and HSP 90 Western blot images in the form of percentages of total intensity of the
bands in a particular membrane (Figure 2). For HSP 70, the general trend was a steady increase
in band intensity followed by a slight decrease after 9 hours. The most intense band occurred at 9
hours, where it made up 14.3% of the total band intensity. The least intense band occurred at 0
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hours, where it made up only 9.4% of the total band intensity. For HSP 90, there was very little
variation in band intensity across the incubation times tested. The most intense band occurred at
18 hours with 13.3% of the total band intensity, but the least intense band was hardly smaller:
11.3% of the total band intensity, occurring at 0 hours. Tubulin showed a steady decrease in band
intensity, with the highest intensity occurring at 0 hours (17.3% of the total band intensity) and
the lowest intensity occurring at 24 hours (5.1% of the total band intensity). Actin followed a
similar general trend in decreasing band intensity; the highest band intensity was at 0 hours
(18.1% of the total band intensity) and the lowest band intensity was at 24 hours (7.2% of the
total band intensity).

4.0 Discussion
4.1 Summary of Results
This study revealed limited information about the expression of HSP 27 in DFTD cells
because it did not appear on any Western blot performed; it was, however, shown to have
significantly increased relative expression of RNA after being heat shocked for several hours.
RNA for HSP 60 was not found to be significantly expressed even after being heat shocked, and
it was not possible to test the actual protein expression. HSP 70 expression increased
significantly after being heat shocked for several hours. Accordingly, the relative expression of
RNA for HSP 70 was found to be increased as heat shocking time increased. Finally, HSP 90
showed little variation in protein expression even after heat shocking, and the same was found to
be true of relative expression of RNA for HSP 90.
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4.2 Western Blot to Determine Presence of HSP 27 and HSP 70
The absence of bands in the Western blot for HSP 27 is unexpected because HSP 27 is
known to be present in S. harrisii (Ensembl, 2014). This could be due to several factors; one
possibility is that either the primary or the secondary antibodies were not concentrated enough
and that they were not binding effectively to HSP 27. The more likely explanation, however, is
that the primary antibody used did not recognize HSP 27 in devils, meaning that it simply does
not react with the target protein as it would in other species. The proper appearance of HSP 70
bands on the same membrane seemed to eliminate human error, such as poor transfer to the
membrane or excessive washing of the membrane, as a reason for the lack of a signal from HSP
27. It would be valuable to repeat this experiment with a different antibody that would perhaps
better react with HSP 27 from DFTD cells.
4.3 Quantitative Reverse Transcriptase PCR of RNA Samples
The quantitative reverse transcriptase PCR of the RNA extracted from the heat shocked
cells showed that overall relative RNA expression was the highest in HSP 27 followed closely by
HSP 70. Because HSPs 27 and 70 both function as chaperone proteins that rescue proteins from
denaturing due to stressful environmental conditions (Lamb et al., 1989), it is logical that their
RNA expression increased with change in an environmental stressor: increasing temperature.
HSPs 60 and 90 showed no significant fold-increase in relative RNA expression when compared
with untreated cells; it is interesting that the cells were not dying despite the fact that certain heat
shock proteins were not being upregulated to help protect other proteins in the cells that were
denaturing from the heat. It is possible that higher heat or different incubation times would result
in higher expression of RNA; a study conducted by Lang et al. (2000) used slightly different
methods to heat shock cells than did this study. Cells were incubated at 47oC in a water bath for
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just 20 minutes. The researchers found that heat shock significantly increased the relative RNA
expression of HSP 70. This is consistent with the results of this study, but it provides valuable
information on alternate methods of heat shocking that could enhance the relative expression of
RNA for heat shock proteins that were not significantly upregulated in this study, including
HSPs 60 and 90.
4.4 Western Blot on Supernatant Samples
The Western blot performed on the supernatant samples from the heat course trial did not
provide much valuable information for this study. The bands seen on all three membranes at
around 55 kDa are mostly likely just signals from fetal calf serum that was present in the cell
culture media. Fetal calf serum is known to have a molecular weight of ~51 kDa (Invitrogen,
n.d.), which validates this claim. There are several possible explanations for the absence of other
bands on all of the membranes; one is that the signal for fetal calf serum was so strong during
imaging that the signals for the HSPs of interest were overshadowed and effectively eliminated
from the image. Another possibility is that the heat shock proteins simply were not released in
large concentrations into the supernatant during heat shocking. According to research conducted
by Basu et al. (2000), it is possible that the heat shock proteins were just not released into the
supernatant. Their study showed that necrotic cell death, but not apoptotic cell death, results in
the release of HSP 70 and HSP 90 into the supernatants. Because the cell viability of all of the
samples after heat shocking was >95%, it is possible that there was a low level of cell death in
culture and thus a low level of HSP release. Further, Lang et al. (2000) found that exposing cells
to heat shock resulted in a rapid and significant upregulation of HSP 70 with no injury to the cell
and without apoptosis occurring.
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4.5 Western Blot on Extracted Protein Samples
The general trends for HSP 70 and HSP 90 observed in the graph of protein band
intensities (Figure 6) agreed with the general trends seen for the same proteins in the graph of
relative RNA expression (Figure 1). In Figure 1, relative RNA expression for HSP 70 was seen
to increase significantly after the 2 hour incubation time point. Similarly, protein expression of
HSP 70 seen in Figure 6 increased steadily to a maximum at 9 hours and then dropped off only
slightly. This shows that incubation at 40oC for increasing lengths of time did have an
upregulatory effect on HSP 70. This result is perfectly consistent with the results from a study
conducted by Dokladny et al. (2006); the researchers found that HSP 70 was increasingly
expressed as heat shock incubation time increased. According to this study, HSP 70 is most
upregulated after 9 hours of incubation at 40oC.
In general, HSP 90 showed very little change in protein expression throughout the heat
course (Figure 6). This was also seen in the graph of relative RNA expression, where none of the
time periods showed a significant fold-change in relative RNA expression. These results differ
from results obtained by Dokladny et al. (2006) in a similar study on intestinal epithelial cells,
which found that increasing time periods of heat shocking was linked with a significant increase
in the expression of HSP 90. Perhaps this difference can be attributed to DFTD cells having a
lower initial concentration of HSP 90 than do intestinal epithelial cells. Additionally, Dokladny
et al. (2006) heated the cells at 41oC as opposed to the 40oC used in this study; it is possible that
this accelerated the upregulation of HSP 90. HSP 90 was most upregulated at 18 hours, though
only marginally.
It is important to note the obvious trend of decreasing protein expression with time in
both the tubulin and the actin protein samples. The controls should have even band intensities
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across the entire membrane, but this was not the case in this experiment. Although this could
cause uncertainty about the credibility of the results, it should instead do the opposite. It would
be expected that if the control bands were decreasing in intensity across the membrane because
of some transfer error or other mistake, the sample bands would be decreasing in intensity as
well. Instead, the sample bands for HSPs 27 and 70 increased steadily, and the band intensity for
HSP 90 did not change significantly. The decrease in protein expression in the controls could
thus be visually lessening the extent to which HSPs 27, 70, and 90 were upregulated. One
explanation for the unusual decrease in expression of both tubulin and actin is that they began to
be degraded over time while being heated in the heat course trial. A study conducted by Kramer
et al. (2008) showed that the transcription of tubulin mRNAs is decreased by as much as 50%
after heat shock, while the maturation of HSP 70 mRNA continues even more efficiently than
before. This is consistent with what was found in this study, that tubulin RNA expression
decreased over time with heat shocking and HSP 70 RNA expression increased with additional
heat shocking. Another study that supports this theory was conducted by Prasad et al. (1998) and
revealed that tubulin undergoes time-dependent decay, or a loss of its functional properties over
time. This effect is especially amplified with heating, as was shown in this study.
4.6 Other Considerations
The vast majority of previous studies investigating the role of heat shock proteins in the
immune system have been conducted in vitro, and the possibility of using them as adjuvants to a
vaccine is still theoretical (Tobian et al., 2004). Heat shock protein behavior in laboratory
settings may deviate from behavior when implanted in vivo.
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5.0 Conclusion and Future Directions
This study aimed to show how heat shocking devil facial tumour disease cells affects the
expression of heat shock proteins 27, 60, 70, and 90. HSPs 27 and 70 had significantly increased
relative RNA expression after heat shocking for increasing lengths of time. As could be
expected, the protein expression for HSP 70 also increased with length of incubation time. HSP
60 showed no significant relative expression of RNA even after heat shocking. Finally, HSP 90
showed insignificant variation in both protein expression and relative RNA expression, even
after heat shocking.
Time was a limiting factor in this study. Further research is required to continue
investigating the possibility of using heat shock proteins as adjuvants to an anti-DFTD vaccine.
An additional heat course study will be conducted in the near future using a different antibody
against HSP 27 to determine protein expression of HSP 27. The results should further support the
findings in this study, that HSP 27 is effectively upregulated with heat shocking. Conducting this
experiment is important, because the results of the present study showed HSP 27 as the most
promising candidate to act as an adjuvant in a vaccine due to its significant increase in
expression after heat shocking.
In addition, it would be valuable to test other methods for heat shocking, such as water
baths for incubation, higher incubation temperatures, and even more variable lengths of time as
did Lang et al. (2000). Testing a wider range of heat shock proteins would be valuable in finding
the most potent inducer of immune function. There is further research currently being done at
Menzies Institute for Medical Research studying toll-like receptor agonists and various anticancer drugs, all for the development of a functioning vaccine against DFTD.
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Appendix 1
Table A1 Summary of two-way ANOVA Dunnett's Multiple Comparisons Test comparing the
relative expression of proteins across incubation time (T=0-24 hours) and gene (HSPs 27, 60, 70,
90). SS=sum of squares, DF=degrees of freedom, MS=mean square, F (DFn, DFd)=F
distribution, P<0.05 considered significant.

Source of Variation
Incubation Time
Gene
Incubation Time x Gene

SS

DF

MS

F (DFn, DFd)

P value

14418
26100
20677

5
3
15

2884
8700
1378

F (5, 10) = 26.28
F (3, 6) = 37.65
F (15, 30) = 15.72

P < 0.0001
P = 0.0003
P < 0.0001

Table A2 Forward and reverse primers used for the quantitative reverse transcriptase PCR of
RNA samples extracted from DFTD cells after heat shocking at 40oC for varying lengths of time
(0-24 hours).
Gene
18S rRNA
HSP70 A2
HSP60 D1
HSP90b (gp96)
HSP27 (B1)

Forward Primer
5' TCGGGACTGCTCTACAAACG 3'
5' GTATTGAAACCGCAGGGGGA 3'
5' AGGCAAGGGTGAAAAATCCCA 3'
5' TTGTTCCCACTTCTGCTCCC 3'
5' ACATTTGCTCGGTCACTCCC 3'

Reverse Primer
5' ACCCTTGATGGCTGTGATGG 3'
5' AGACACTGCTCTGGTTGTCG 3'
5' AAGCAATGCACAACCACCAC 3'
5' AGCCGAGTACGGTTGGAATG 3'
5' AAGCCGTGCTCATCTTGTCT 3'
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